Seeking AlphaWed, 08 Apr 2026 20:14:01 GMTStructure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy Meets Biased-Agonism Safety MoatGPCR-0.13%
BenzingaWed, 01 Apr 2026 18:07:40 GMTWhat's Going On With Structure Therapeutics Stock On Wednesday?GPCR-0.13%
Seeking AlphaFri, 27 Mar 2026 12:15:17 GMTStructure Therapeutics: A High-Risk, High-Reward Bet On The Next GLP-1 BlockbusterGPCR-0.13%
The Motley FoolSun, 22 Mar 2026 20:06:16 GMTStructure Therapeutics Slides 28% This Year as $6 Million Stake EmergesGPCR-0.13%
Seeking AlphaTue, 17 Mar 2026 11:45:31 GMTStructure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition TargetGPCR-0.13%
The Motley FoolFri, 27 Feb 2026 15:52:38 GMTStructure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 MillionGPCR-0.13%
The Motley FoolWed, 25 Feb 2026 20:35:37 GMTStructure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million PositionGPCR-0.13%
Seeking AlphaWed, 18 Feb 2026 21:51:24 GMTStructure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough?GPCR-0.13%
